Search research articles
Contact Us
Filters
Showing results (151-160 of 160) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 160 results.
The Journal of Clinical Investigation
|
December 1, 1991
Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation
T Hongo, J Kupfer, H Enomoto, et al.
The American Journal of Medicine
|
March 1, 1983
Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia
A B Hodsman, E G Wong, D J Sherrard, et al.
The Journal of Clinical Investigation
|
June 23, 2000
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone
C Menaa, S V Reddy, N Kurihara, et al.
Archives of Internal Medicine
|
November 1, 1974
1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy
A S Brickman, D J Sherrard, J Jowsey, et al.
Life Sciences
|
May 3, 1982
Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man
M E Berger, M S Golub, J R Sowers, et al.
Annals of Internal Medicine
|
May 1, 1981
Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism
A B Hodsman, D J Sherrard, E G Wong, et al.
Human Molecular Genetics
|
December 14, 2001
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene
E Cleiren, O Bénichou, E Van Hul, et al.
The American Journal of Medicine
|
August 1, 1995
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling
C H Chesnut, M R McClung, K E Ensrud, et al.
The American Journal of Medicine
|
November 14, 1997
Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women
J L Stock, N H Bell, C H Chesnut, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 17, 1998
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study
E S Siris, A A Chines, R D Altman, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 160) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 160 results.
The Journal of Clinical Investigation
|
December 1, 1991
Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation
T Hongo, J Kupfer, H Enomoto, et al.
The American Journal of Medicine
|
March 1, 1983
Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia
A B Hodsman, E G Wong, D J Sherrard, et al.
The Journal of Clinical Investigation
|
June 23, 2000
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone
C Menaa, S V Reddy, N Kurihara, et al.
Archives of Internal Medicine
|
November 1, 1974
1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy
A S Brickman, D J Sherrard, J Jowsey, et al.
Life Sciences
|
May 3, 1982
Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man
M E Berger, M S Golub, J R Sowers, et al.
Annals of Internal Medicine
|
May 1, 1981
Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism
A B Hodsman, D J Sherrard, E G Wong, et al.
Human Molecular Genetics
|
December 14, 2001
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene
E Cleiren, O Bénichou, E Van Hul, et al.
The American Journal of Medicine
|
August 1, 1995
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling
C H Chesnut, M R McClung, K E Ensrud, et al.
The American Journal of Medicine
|
November 14, 1997
Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women
J L Stock, N H Bell, C H Chesnut, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 17, 1998
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study
E S Siris, A A Chines, R D Altman, et al.
Page
of 16